Showing results (51-60 of 64) with videos related to
Sort By:
Pageof 7
International Journal of Cancer|January 8, 2013
Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosisEline H van Roekel, Kar K Cheng, Nicholas D James, et al.Lancet (London, England)|February 17, 2009
Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trialAnnie M Young, Lucinda J Billingham, Gulnaz Begum, et al.Statistical Applications in Genetics and Molecular Biology|October 4, 2007
Multiple testing issues in discriminating compound-related peaks and chromatograms from high frequency noise, spikes and solvent-based noise in LC-MS data setsStephen O Nyangoma, Antoine A H C van Kampen, Theo H Reijmers, et al.Genes and Immunity|June 11, 2004
Extended haplotypes and linkage disequilibrium in the IL1R1-IL1A-IL1B-IL1RN gene cluster: association with knee osteoarthritisA J P Smith, L J Keen, M J Billingham, et al.Gene Therapy|February 11, 2011
Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanomaJ C Steele, A Rao, J R Marsden, et al.Blood|July 9, 1999
Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's diseaseP G Murray, L J Billingham, H T Hassan, et al.JAMA Network Open|October 17, 2023
Selenium and Vitamin E for Prevention of Non-Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical TrialRichard T Bryan, Sarah J Pirrie, Ben Abbotts, et al.Proteomics. Clinical Applications|August 2, 2011
Assessment of high-throughput high-resolution MALDI-TOF-MS of urinary peptides for the detection of muscle-invasive bladder cancerRichard T Bryan, Wenbin Wei, Neil J Shimwell, et al.Aviation, Space, and Environmental Medicine|April 11, 1975
The effects of cosmic particle radiation on pocket mice aboard Apollo XVII: IX Results of examination of the nasal mucosaL M Kraft, F S Vogel, B Lloyd, et al.JAMA Oncology|January 23, 2016
Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical TrialNicholas D James, Sarah J Pirrie, Ann M Pope, et al.Pageof 7